FCGR3A and neoplasm: Several studies have confirmed that the Fc receptor CD16 (CD16A, FcγRIII) is the most effective activating receptor expressed in NK cells, resulting in ADCC-triggered tumor cell lysis when IgG-coated target cells bind to it and occur independently of other co-activating receptors (16, 17).